ST
NVO

Smithfield Trust’s Novo Nordisk NVO Stock Holding History

Smithfield Trust’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2K Sell
68
-2
-3% -$95 ﹤0.01% 1048
2025
Q4 		$3K Buy
+70
New +$3.58K ﹤0.01% 1030
2024
Q2 		– Sell
-30
Closed -$5K – 1059
2024
Q1 		$5K Buy
+30
New +$3.57K ﹤0.01% 936
2015
Q2 		– Sell
-3,840
Closed -$102K – 817
2015
Q1 		$102K Hold
3,840
– – 0.02% 399
2014
Q4 		$81K Sell
3,840
-2,010
-34% -$44.9K 0.02% 430
2014
Q3 		$139K Sell
5,850
-360
-6% -$8.28K 0.03% 358
2014
Q2 		$143K Sell
6,210
-3,740
-38% -$82.6K 0.03% 398
2014
Q1 		$227K Hold
9,950
– – 0.05% 310
2013
Q4 		$184K Buy
9,950
+4,990
+101% +$87K 0.04% 356
2013
Q3 		$84K Buy
+4,960
New +$83.4K 0.02% 432

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Smithfield Trust's NVO Position: Q1 2026 in Review

Smithfield Trust reduced its Novo Nordisk (NVO) stake by 2.9% in Q1 2026, selling an estimated $95 and leaving 68 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #1048.

Smithfield Trust first reported a position in NVO in Q3 2013 and has held it in 10 quarters since. The position peaked at $227K in Q1 2014. 1,271 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Smithfield Trust held 68 shares of Novo Nordisk worth $2K as of Q1 2026.
  • Smithfield Trust sold 2 Novo Nordisk shares in Q1 2026, an estimated $95.
  • Novo Nordisk made up ﹤0.01% of Smithfield Trust's portfolio in Q1 2026, its #1048 holding.
  • Smithfield Trust first reported a position in Novo Nordisk in Q3 2013 and has held it in 10 quarters since.
  • Smithfield Trust's Novo Nordisk position peaked at $227K in Q1 2014.
  • 1,271 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Smithfield Trust's 13F filing for Q1 2026, filed 8 May 2026.